Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection

References

• RusinPARoseJBHaasCNGerbaCPRisk assessment of opportunistic bacterial pathogens in drinking waterRev Environ Contam Toxicol199715257839297985
   PubMedGoogle Scholar
• DegoricijaVSkerkVVatavukZKnezevićTSeferSVućicevićZBilateral Pseudomonas aeruginosa endogenous endophthalmitis in an immune-competent patient with nosocomial urosepsis following abdominal surgeryActa Clin Croat20115026126622263394
   PubMed Web of Science ®Google Scholar
• WildeboerDHillKEJeganathanFSpecific protease activity indicates the degree of Pseudomonas aeruginosa infection in chronic infected woundsEur J Clin Microbiol Infect Dis20120934–972317
   Google Scholar
• DickinsonGMBisnoALInfections associated with indwelling devices: Infections related to extravascular devicesAntimicrob Agents Chemother1989336026072665638
   PubMed Web of Science ®Google Scholar
• SchryversABOgunariwoJChamberlandSGodfreyAJRabinHRBryanLEMechanism of Pseudomonas aeruginosa persistence during treatment with broad-spectrum cephalosporins of lung infections in patients with cystic fibrosisAntimicrob Agents Chemother198731143814393118800
   PubMed Web of Science ®Google Scholar
• WeberDJRutalaWASickbert-BennettEESamsaGPBrownVNiedermanMSMicrobiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumoniaInfect Control Hosp Epidemiol20072882583117564985
   PubMed Web of Science ®Google Scholar
• CrossAAllenJRBurkeJNosocomial infections due to Pseudomonas aeruginosa: review of recent trendsRev Infect Dis19835SupplS837S8456361960
   PubMedGoogle Scholar
• SaimanLInfection prevention and control in cystic fibrosisCurr Opin Infect Dis20112439039521543979
   PubMed Web of Science ®Google Scholar
• LangABHornMPImbodenMAZuercherAWProphylaxis and therapy of pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patientsVaccine200422SupplS44S4815576201
   PubMed Web of Science ®Google Scholar
• YoshizawaSFourmyDPuglisiJDStructural origins of gentamicin antibiotic actionEMBO J199817643764489822590
   PubMed Web of Science ®Google Scholar
• TangeRADreschlerWAPrinsJMBullerHRKuijperEJSpeelmanPOtotoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. a randomized clinical trialClin Otolaryngol Allied Sci1995201181237634515
   PubMed Web of Science ®Google Scholar
• LećarozCBlanco-PrietoMJBurrellMAGamazoCIntracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicinJ Antimicrob Chemother20065854955616799160
   PubMed Web of Science ®Google Scholar
• LuEFranzblauSOnyukselHPopescuCPreparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterionJ Microencapsul20092634635418726818
   PubMed Web of Science ®Google Scholar
• SolimanGMSzychowskiJHanessianSWinnikFMRobust polymeric nanoparticles for the delivery of aminoglycoside antibiotics using carboxymethyldextran-b-poly(ethyleneglycols) lightly grafted with n-dodecyl groupsSoft Matter2010645044514
   Web of Science ®Google Scholar
• Pinto-AlphandaryHAndremontACouvreurPTargeted delivery of antibiotics using liposomes and nanoparticles: research and applicationsInt J Antimicrob Agents20001315516810724019
   PubMed Web of Science ®Google Scholar
• CouvreurPFattalEAndremontALiposomes and nanoparticles in the treatment of intracellular bacterial infectionsPharm Res19918107910861788152
   PubMed Web of Science ®Google Scholar
• GaoPNieXZouMShiYChengGRecent advances in materials for extended-release antibiotic delivery systemJ Antibiot (Tokyo)20116462563421811264
   PubMed Web of Science ®Google Scholar
• SeleemMNMunusamyPRanjanAAlqublanHPickrellGSriranganathanNSilica-antibiotic hybrid nanoparticles for targeting intracellular pathogensAntimicrob Agents Chemother2009534270427419667284
   PubMed Web of Science ®Google Scholar
• MohammadiGValizadehHBarzegar-JalaliMDevelopment of azithromycin-PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhiColloids Surf B Biointerfaces201080343920558048
   PubMed Web of Science ®Google Scholar
• PillaiRRSomayajiSNRabinovichMHudsonMCGonsalvesKENafcillin-loaded PLGA nanoparticles for treatment of osteomyelitisBiomed Mater2008303411418708713
   PubMed Web of Science ®Google Scholar
• KashiTSEskandarionSEsfandyari-ManeshMImproved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing methodInt J Nanomedicine2012722123422275837
   PubMed Web of Science ®Google Scholar
• BensonJRHarePEO-phthalaldehyde: Fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrinProc Natl Acad Sci U S A1975726196221054843
   PubMed Web of Science ®Google Scholar
• FayFQuinnDJGilmoreBFMcCarronPAScottCJGene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticlesBiomaterials2010314214422220185174
   PubMed Web of Science ®Google Scholar
• KhanWBernierSPKuchmaSLHammondJHHasanFO’TooleGAAminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharideInt Microbiol20101320721221404215
   PubMed Web of Science ®Google Scholar
• CeriHOlsonMEStremickCReadRRMorckDBuretAThe Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilmsJ Clin Microbiol1999371771177610325322
   PubMed Web of Science ®Google Scholar
• TrnovecTDurisováMBezekSPharmacokinetics of gentamicin administered intratracheally or as an inhalation aerosol to guinea pigsDrug Metab Dispos1984126416446149918
   PubMed Web of Science ®Google Scholar
• Di RoccoaPHNacucchioMCSordelliDOAerosol treatment with cefoperazone or gentamicin protects granulocytopenic mice from acute Pseudomonas aeruginosa pneumoniaEur J Pharm Sci19941285289
   Web of Science ®Google Scholar
• LüJMWangXMarin-MullerCCurrent advances in research and clinical applications of PLGA-based nanotechnologyExpert Rev Mol Diagn2009932534119435455
   PubMed Web of Science ®Google Scholar
• DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release20121650552222353619
   PubMed Web of Science ®Google Scholar
• GiteauAVenier-JulienneMCMarchalSReversible protein precipitation to ensure stability during encapsulation within PLGA microspheresEur J Pharm Biopharm20087012713618448319
   PubMed Web of Science ®Google Scholar
• SongXZhaoYHouSDual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiencyEur J Pharm Biopharm20086944545318374554
   PubMed Web of Science ®Google Scholar
• SmithALDaumRSSiberGRScheifeleDWSyriopoulouVPGentamicin penetration into cerebrospinal fluid in experimental Haemophilus influenzae meningitisAntimicrob Agents Chemother198832103410393190192
   PubMed Web of Science ®Google Scholar
• RukholmGMugabeCAzghaniAOOmriAAntibacteria activity of liposomal gentamicin on pseudomonas aeruginosa: A time-kill studyInt J Antimicrob Agents20062724725216472992
   PubMed Web of Science ®Google Scholar
• OwensDE3rdPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMed Web of Science ®Google Scholar
• SemeteBBooysenLLemmerYIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine2010666267120230912
   PubMed Web of Science ®Google Scholar
• RaoSCSrinivasjoisRHaganRAhmedMOne dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonatesCochrane Database Syst Rev201111CD00509122071818
   PubMed Web of Science ®Google Scholar
• BestEJGazarianMCohnRWilkinsonMPalasanthiranPOnce-daily gentamicin in infants and children: A prospective cohort study evaluating safety and the role of therapeutic drug monitoring in minimizing toxicityPediatr Infect Dis J20113082783221577177
   PubMed Web of Science ®Google Scholar